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L i p o p o l y s a c c h a r i d e is a f r e q u e n t c o n t a m i n a n t o f p l a s m i d 
D N A p r e p a r a t i o n s a n d c a n b e t o x i c to p r i m a r y h u m a n 
c e l l s i n t h e p r e s e n c e of a d e n o v i r u s 
M a t t C o t t e n 1 , A d a m Baker 1 , M e d i y h a Salt ik 1 , Ernst W a g n e r 1 2 and M i c h a e l Buschle 2 
T M P , Research I n s t i t u t e of M o l e c u l a r Pathology, D r Bohrgasse 7 , 1 0 3 0 V i e n n a and2 Bender & Co., E r n s t Boehringergasse 5 - 1 1 , 
1121 V i e n n a , A u s t r i a 
E n d o t o x i n ( l i p o p o l y s a c c h a r i d e , L P S ) i s c o m m o n l y f o u n d a s a 
c o n t a m i n a n t i n p l a s m i d D N A p r e p a r a t i o n s . We d e m o n s t r a t e 
h e r e t h a t t h e q u a n t i t i e s of L P S t y p i c a l l y c o n t a m i n a t i n g D N A 
p r e p a r a t i o n s c a n g e n e r a l e a t o x i c i t y t o p r i m a r y c e l l s ( p r i m a r y 
h u m a n s k i n f i b r o b l a s t s , p r i m a r y h u m a n m e l a n o m a c e l l s ) i n t h e 
p r e s e n c e o f e n t r y - c o m p e t e n t a d e n o v i r u s p a r t i c l e s . T o x i c i t y 
c a n b e o b s e r v e d w i t h a s l i t t l e a s 100 n g / m l f r e e L P S o r 100 
p g / m l L P S w h e n t h e L P S i s a s s e m b l e d i n t o p o l y l y s i n e / a d e n o -
v i r u s c o m p l e x e s . S i m p l e a n d e f f e c t i v e m e t h o d s o f r e m o v i n g 
t h e c o n t a m i n a t i n g L P S u s i n g e i t h e r a p o l y m y x i n B r e s i n o r 
Triton X - 1 1 4 e x t r a c t i o n a r e d e s c r i b e d . T r e a t m e n t o f D N A 
s a m p l e s t o r e m o v e L P S e l i m i n a t e s t h e t o x i c i t y t o p r i m a r y c e l l s . 
I n t r o d u c t i o n 
E n d o t o x i n ( l ipopolysacchar ide , LPS) is a major 
c o m p o n e n t of the G r a m - n e g a t i v e bacterial cell w a l l . The 
L P S m o n o m e r is a d i g l u c o s a m i n e d i p h o s p h a t e bear ing 
six l i p i d moiet ies , l i n k e d to either t w o or three 2-keto-3-
deoxyoctonate ( K D O ) residues l i n k e d to a n inner core of 
carbohydra te res idues l i n k e d to the outer (O-antigen) 
c a r b o h y d r a t e residues (see [1, 2] for details) . The L P S 
m o l e c u l e is a n extremely potent s t i m u l a t o r of the 
m a m m a l i a n i m m u n e System a n d a n u m b e r of 
m e c h a n i s m s exist to detect L P S a n d to r e s p o n d to the 
presence of e i ther this molecu le or G r a m - n e g a t i v e 
bacteria [3-12]. L P S is a c o m m o n contaminant of p l a s m i d 
D N A preparat ions g r o w n i n Escherichia c o l i . U p to 40% 
of the surface L P S of E. coli can be released by treating 
intact bacteria w i t h T r i s / E D T A Solutions I i , 13], 
c o n d i t i o n s that are n o r m a l l y used i n the in i t ia l Steps of 
p r e p a r i n g p l a s m i d D N A . The negative charges 
associated w i t h the l i p i d A a n d inner core of L P S cause 
the L P S m o l e c u l e to behave l i k e D N A o n a n i o n 
exchange Chromatographie resins. The large size of the 
m i c e l l a r f o r m of L P S causes the m o l e c u l e to behave l ike 
a large D N A m o l e c u l e o n size e x c l u s i o n resins. The 
d e n s i t y of L P S i n C s C l is s i m i l a r to that of p l a s m i d - E t B r 
complexes (1.37 g / m l versus 1.5 g/ml) , so that C s C l -
b a n d e d D N A can be easi ly contaminated . W e d o c u m e n t 
here a toxic i ty i n p r i m a r y h u m a n s k i n f ibroblasts as w e l l 
as p r i m a r y h u m a n m e l a n o m a cells exposed to L P S -
c o n t a i n i n g D N A or p u r e L P S i n the presence of 
a d e n o v i r u s . T o x i c i t y appears at levels of 100 n g / m l free 
L P S or 100 p g / m l w h e n the L P S is assembled into 
p o l y l y s i n e / a d e n o v i r u s complexes . M e t h o d s to r e m o v e 
the c o n t a m i n a t i n g L P S a n d e l iminate the toxic i ty are 
descr ibed. 
C o r r e s p o n d e n c e : M a t t C o t t e n , 1MP, Research I n s t i t u t e of Molecular 
P a t h o l o g y , Dr Bohrgasse 7 , 1 0 3 0 V i e n n a , A u s t r i a 
R e s u l t s 
F r a c t i o n a t i o n of C s C l g r a d i e n t to s h o w p o s i t i o n of LPS 
r e l a t i v e t o D N A 
The p l a s m i d p C L u c w a s g r o w n i n E. coli DH~5cx i n the 
presence of 100 ( i g / m l a m p i c i l l i n a n d a cleared lysate of 
the bacteria was prepared and fractionated by C s C l 
densi ty gradient centr i fugat ion (see Mater ia l s a n d 
methods) . The gradient w a s subsequent ly fractionated (2 
m l fractions) and fractions f r o m the gradient (2 ml) were 
assayed for p l a s m i d D N A content ( A M ) and gel 
electrophoresis) a n d L P S content ( L i m u l u s assay). The 
results are s h o w n i n F igure 1. W e f i n d that the o r i g i n a l 
cleared lysate contains L P S at more than 500 000 
e n d o t o x i n uni ts ( E U ) / m l (>500 ( i g / m l ; results not 
1000 000 f 1 
100 000 
1000 
Fraction number (1 = bottom) 
F i g u r e 1 L o c a t i o n of L P S in C s C ! d e n s i t y g r a d i e n t p u r i f i c a t i o n of p l a s m i d 
D N A . A cleared l y s a t e of E . c o l i b e a r i n g a n a m p i c i l l i n r e s i s t a n c e p l a s m i d was 
p r e p a r e d a n d subjected t o C s C l d e n s i t y g r a d i e n t c e n t r i f u g a t i o n in t h e 
presence o f e t h i d i u m b r o m i d e as described in t h e M a t e r i a l s a n d m e t h o d s . 
After 18 h a t 2 0 0 0 0 0 x g ( B e c k m a u VTiSO r o t o r ) t h e g r a d i e n t was 
p a r t i t i o u e d i n t o 22 f r a c t i o n s . F r a c t i o n s w e r e a n a l y z e d f o r p l a s m i d D N A 
c o n t e n t b y agarose gel e l e c t r o p h o r e s i s a n d for L P S c o n t e n t b y l i m u l u s assay. 
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s h o w n ) . This is not s u r p r i s i n g as T r i s / E D T A treatment of 
Gram-negat ive bacteria releases large amounts of L P S |1, 
13]. A f t e r a Single fract ionation o n a C s C l gradient , w e 
f ind that the p l a s m i d D N A , as expected, bands near the 
m i d d l e of the gradient (centered a r o u n d fraction 14) 
w h i l e the b u l k of the L P S is present i n fractions near the 
top of the gradient . Substantial amounts of L P S , 
h o w e v e r , are dis t r ibuted t h r o u g h o u t the infer ior of the 
gradient so that the p l a s m i d D N A - b e a r i n g fractions s t i l l 
contain as m u c h as 10 u g / m l L P S , aecounting for the L P S 
content of C s C l - p u r i f i e d D N A samples (see Table 1). 
Table 1 LPS content of D N A preparations 
M e t l w d N o . M e a n LPS c o n t e n t Range 
of samples ( E U / 6 ug D N A ) ( E U / 6 \ig D N A ) 
D N A preparation 
C s C l 13 4.3 0.6 - >25 
Qiagen 5 10.3 3.8 - >25 
Nucleobond 7 20.2 0.5 - >25 
Treatment to remove LPS 
CsCl/Tri ton X-114 7 0.09 0.05-0.195 
Qiagen/Triton X-114 4 0.08 0.016-0.2 
Nucleobond/polymyxin 7 0.02 0.001 - 0.075 
Note: 1 E U (endotoxin unit) ~ 1 ng LPS 
LPS c o n t e n t of D N A p r e p a r e d b y d i f f e r e n t m e t h o d s 
C o l u m n Chromatographie m e t h o d s of p u r i f y i n g p l a s m i d 
D N A fractionate the D N A based largeiy on its charge 
densi ty . The L P S molecu le possesses a h i g h negative 
charge densi ty d u e to the presence of phosphate g r o u p s 
on the l i p i d A moie ty as w e l l as phosphate and c a r b o x y l 
g r o u p s o n the octolonic acid sugar g r o u p s ( rev iewed i n 
[1, 2]). Because of the negative charge densi ty of L P S as 
w e l l as the molecule ' s ab i l i tv to assemble into h i g h 
molecu lar we ight micel les , the L P S has a strueture that 
shares features w i t h the chemis t ry and size of p l a s m i d 
D N A . Ion-exchange resins used for p u r i f y i n g p l a s m i d 
D N A (e.g. Q i a g e n , N u c l e o b o n d ) generate p l a s m i d 
preparat ions that conta in s igni f icant quanti t ies of L P S 
(see Table 1). L i k e D N A , L P S preeipitates f r o m ethanol 
a n d i s o p r o p a n o l Solutions. Fur thermore , because the 
L P S is not detected b y either e t h i d i u m b r o m i d e s ta in ing 
i n agarose electrophoresis or b y absorbance at 260 n m , 
the presence of L P S can be largelv undetected in D N A 
preparat ions . Table 1 lists the L P S Contents of p l a s m i d 
D N A prepared b y a var iety of methods . 
W e have subjected three types of D N A preparat ions to 
t w o methods of L P S r e m o v a l . A s imple and effective 
method of L P S r e m o v a l e m p l o y s the detergent Tr i ton X -
114. A t temperatures b e l o w its c loud point of 20°C, T r i t o n 
X - l 14 is miscible w i t h aqueous Solutions; at temperatures 
above 20°C, the detergent part i t ions into a separate phase 
[14]. This phase par t i t ioning can be used to extract the 
l i p o p h i l i c L P S molecule f r o m aqueous protein Solutions 
[15] as w e l l as D N A preparat ions [16], A n alternative L P S 
r e m o v a l method e m p l o y s p o l y m y x i n B, a cyclic fungal 
pept ide that b inds the l i p i d A / K D O component of L P S 
w i t h h igh aff inity [9,17,18]. C h r o m a t o g r a p h i e resins 
bearing this pept ide can be used to remove L P S f r o m 
protein or D N A Solutions. W e obtain s i m i l a r L P S r e m o v a l 
success w i t h either m e t h o d (Table 1). Both the T r i t o n 
extraction m e t h o d a n d the p o l y m y x i n resin generate 
D N A preparat ions w i t h comparable absence of L P S (<0.1 
E U / 6 u g D N A ) . W e have occasional ly encountered 
di f f i cul ty u s i n g either m e t h o d to r e m o v e the L P S that 
contaminates C s C l p u r i f i e d D N A . It is possible that the 
C s C l pur i f i ca t ion enriches for a f o r m of L P S that does not 
a v i d l y b i n d either the detergent phase or the p o l y m y x i n . 
S o d i u m d o d e c y l s u l f a t e / p o l y a c r y l a m i d e gel 
electrophoresis ( S D S / P A G E ) resolut ion of D N A samples 
stained w i t h an LPS-specif ic sih'er stain [19, 20) 
demonstrates that the f o r m of L P S most f requent ly f o u n d 
contaminat ing D N A preparat ions is a h igher molecular 
weight , heterogeneous f o r m of L P S consistent w i t h the 
s m o o t h L P S phenotvpe of the E. c o l i strains used to 
propagate the p l a s m i d D N A (results not s h o w n ) . 
T o x i c i t y of L P S t o p r i m a r y c e l l s in t h e p r e s e n c e of 
a d e n o v i r u s 
In a n i n i t i a l s t u d y to d e t e r m i n e if L P S c o u l d generate a 
toxic i ty to m a m m a l i a n cells, cul tures of p r i m a r y h u m a n 
m e l a n o m a cells were exposed to p u r i f i e d L P S samples 
( f rom either E. c o l i 0111 :B4 or S a l m o n e l l a m i n n e s o t a ) i n the 
absence or presence of psora len- inact ivated a d e n o v i r u s 
dII014. A f t e r 48 h , the cul tures w e r e processed to 
de termine s u r v i v i n g cells b y w a s h i n g the cell m o n o -
layers, f i x i n g w i t h f o r m a l d e h y d e a n d s ta in ing w i t h 
crystal violet (F igure 2) or i n e u b a t i n g w i t h the v i a b i l i t y 
stain M T T (3-[4 ,5-dimethylthiazol-2-yl] -2 ,5-
d i p h e n y l t e t r a z o l i u m ) (Figure 3). 
W e f i n d that ineubat ion of p r i m a r y cells w i t h L P S 
alone (up to 250 u g / m l ) or psoralen- inact ivated 
a d e n o v i r u s alone (up to K T v i r u s particles/cell) has no 
toxic effect (Figure 2a). H o w e v e r , c o m b i n e d treatment of 
these cells w i t h mature a d e n o v i r u s (10 5 v i r u s part ic les/ 
cell) p l u s L P S ( d o w n to 50 n g / m l ) k i l l s these cul tures , as 
measured by crystal v io le t s ta in ing (F igure 2a). 
P u r i f i e d preparat ions of i m m a t u r e a d e n o v i r u s 
particles ( w i t h a dens i ty of 1.31 g/cm 3 ) possess the füll 
c o m p l e m e n t of outer caps id prote ins yet are defect ive at 
ce l lu lar entry a n d c y t o p l a s m i c release of co-enciocytosed 
mater ia l [21,'22] ( M ' . C . a n d M . S . , u n p u b l i s h e d results) . 
These i m m a t u r e a d e n o v i r u s part ic les are an a s s e m b l v 
intermediate , are def ic ient for v i r a l D N A (hence their 
l ighter densi ty) a n d are inact ive in the p H - d e p e n d e n t 
m e m b r a n e d i s r u p t i o n reaction that is r e q u i r e d for 
a d e n o v i r u s entry into host cells ( M . C . a n d M . S . , 
u n p u b l i s h e d results). E x p o s u r e to L P S i n the presence of 
i m m a t u r e a d e n o v i r u s particles does not result i n ce l lu lar 
toxic i ty (F igure 2b), d e m o n s t r a t i n g that c y t o p l a s m i c 
entry of the a d e n o v i r u s (and p o s s i b l v co-entry of LPS) is 
r e q u i r e d for toxic i tv . 
W h e n the v i a b i l i t y stain M T T is u s e d to measure 
toxic i ty in the presence of m a t u r e v i r u s part ic les a n d 
L P S , s i m i l a r results are obta ined (F igure 3). N o toxic i ty 
is apparent w i t h L P S alone, a s l ight dec l ine i n v i a b i l i t y is 
o b s e r v e d w i t h a d e n o v i r u s alone (10 000 or 100 000 v i r u s 
particles per cell) but a severe dec l ine i n v i a b i l i t y is 
observed w i t h the higher v i r u s i n p u t i n the presence of 
L P S (Figure 3). 
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F i g u r e 2 L P S is t o x i c t o p r i m a r y h u m a n melanoma cells in t h e presence of 
m a t u r e l u d n o t i m m a t u r e a d e n o v i r u s p a r t i c l e s . P r i m a r y h u m a n melanoma 
cells ( i s o l a l e I I 2 2 6 ) were p l a t e d al 40 0 0 0 cells per w e l l of a 2 4 - w e l l d i s h . The 
cells were exposed t o t h e i n d i c a t e d q u a n t i t i e s of L P S ( S . m i n n e s o t a w i l d t y p e ) 
and a d e n o v i r u s [ ( a ) d l l 0 1 4 , p s o r a l e n - i n a c t i v a t e d ; ( b ) d l l 0 l 4 , l i g h t . 1.31 
g / c m 3 p a r t i c l e s ] in I m l of DMEM/2'A horse s c r u m for 2 h a t 37°C, after 
w h i c h I m l of RPMI/10'7, PCS were added. After 48 I i , t h e cell samples were 
washed once w i t h H B S , f i x e d in f o r m a l d e h y d e and s t a i n e d w i t h c r y s t a l v i o l e t 
(see M a t e r i a l s u n d m e t h o d s ) . 
S i m i l a r toxicit ies are observed w i t h E. c o l i 0111 :B4 
L P S (smooth) , S. m i n n e s o t a w i l d type L P S (smooth) a n d 
S. m i n n e s o t a Re 595 L P S ( rough E; results not s h o w n ) . 
The v i r u s a n d L P S m u s t be exposed to cells 
s i m u l t a n e o u s l y to generate the toxici ty. E x p o s u r e to 
v i r u s or L P S alone for 2 h f o l l o w e d by w a s h i n g and then 
exposure to the second c o m p o n e n t does not result in 
toxic i ty (results not s h o w n ) . The toxici tv does not appear 
to i n v o l v e a d e n o v i r u s gene express ion. N o v i r a l gene 
express ion can be detected w i t h psoralen- inact ivated 
a d e n o v i r u s d l l 0 1 4 (results not s h o w n ) a n d s i m i l a r levels 
of L P S tox ic i ty are observed w i t h either psora len-
inact ivated a d e n o v i r u s d l l 0 1 4 or non- inac t iva ted d l l 0 1 4 . 
A l t h o u g h w e have not yet p e r f o r m e d a n exhaust ive 
s u r v e y , the toxic response appears to be a funet ion of 
p r i m a r y cel l cul tures a n d the toxic response does not 
occur w i t h establ ished cell l ines (e.g. H e L a , V e r o , 3T3 or 
K562). In a d d i t i o n , there appear to be species differences 
i n the response to L P S / a d e n o v i r u s toxic i ty . W e have 
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F i g u r e 3 T o x i c i t y t o p r i m a r y h u m a n melanoma cells in t h e presence offrec 
L P S and a d e n o v i r u s . P r i m a r y h u m a n melanoma cells ( i s o l a t e H 2 2 5 ) were 
p l a t e d a t 4 0 0 0 cells per w e l l ofa 9 6 - w e l l d i s h . T r i p l i c a t e samples ( i n 1 0 0 yd of 
D M F . M , 2% H S ) were ineubated w i t h t h e i n d i c a t e d q u a n t i t y of L P S 
( S . m i n n e s o t a w i l d t y p e t in e i t h e r t h e absence of v i r u s , or t h e presence of 10 
0 0 0 or 1 0 0 0 0 0 p a r t ' i e l e s / c e l l of a d e n o v i r u s dllO'14 ( p s o r a l e n i n a c t i v a t e d ) . 
A f t e r 2 h . 1 0 0 u/ of R P M I 1 6 4 0 / 1 0 % FCS was added t o each w e l l ; 48 h l a i e r 
t h e m e d i u m was replaced w i t h 100 u l of R P M I 1 6 4 0 / 1 0 % FCS p l u s 15 u/ of 
M T T r c a g e n t ( P r o m e g a ) , processed a e c o r d i n g t o t h e m a u u f a c t u r e r ' s 
d i r e c t i o u s and t h e absorbaucc at 5 4 0 u m ( s u b t r a c t i u g a b a c k g r o u u d al 6 2 0 
n i n l was measured w i t h a n E L I S A p l a t e reader. Fach p o i n l in t h e g r a p l i 
represents t h e average of t h r e e i n d e p e n d e n t samples. 
sensit ive to the toxic i ty but p r i m a r y c h i c k e n e m b r y o 
f ibroblasts a n d p r i m a r y d o g musc le f ibroblasts are not 
sensit ive. 
P u r i f i c a t i o n of D N A e l i m i n a t e s t o x i c i t y 
Several preparat ions of p C S - h I L - 2 , a p l a s m i d bear ing the 
h u m a n i n t e r l e u k i n 2 (1L-2) gene d r i v e n b y the C M V 
promoter , were p u r i f i e d w i t h a m o d i f i e d N u c l e o b o n d 
protoeol (see Mater ia ls and methods) a n d the L P S 
content was found to ränge f r o m 0.5 to >25 E U / 6 u g 
D N A (Figure 4). Each p l a s m i d preparat ion was subjected 
to p o l y m y x i n B c h r o m a t o g r a p h y or T r i t o n X-114 
extraction to r e m o v e L P S . A f t e r treatment, a l l samples 
contained less than 0.1 E U / 6 u g D N A . The o r i g i n a l a n d 
the p u r i f i e d D N A preparat ions were then assembled into 
a d e n o v i r u s s t r e p t a v i d i n - p o l y l y s i n e - ( S t r p L ) - t r a n s f e r r i n -
p o l y l y s i n e (TfpL) complexes and transfected into 
p r i m a r y h u m a n m e l a n o m a cells. The cul ture 
supernatants at 24-48 h post-transfection were harvested 
and the IL-2 content w a s measured b y e n z y m e - l i n k e d 
i m m u n o s o r b e n t assay ( E L I S A ) . In a l l cases w e f i n d that 
L P S r e m o v a l leads to increased gene express ion ( from 
3-26- fo ld ; F igure 4). F r o m the m o r p h o l o g y of the 
transfected cultures at 48 h post-transfection, cel lular 
toxici ty c o u l d easily aecount for the p o o r IL-2 express ion 
f r o m the L P S - b e a r i n g D N A samples . 
LPS a s s e m b l e d i n t o p o l y l y s i n e c o m p l e x e s is m o r e t o x i c 
t h a n free LPS 
T h e Observation of tox ic i ty that ini t iated this 
inves t iga t ion w a s d u e to L P S c o n t a m i n a t i o n of D N A 
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M . C o t t e n et al. 
L P S 
Purification 
EU 
per 6 Mg 
DNA o 
IL-2 (units/10 t o cells/24 hours) 








Polymyxin B <0.1 










F i g u r e 4 P r i m a r y h u m a n melanoma cells ( i s o l a t e H 225, 2 x 1 0 5 cells/6 cm 
d i s h ) were t r a n s f e c t e d w i t h 6 \lg o f v a r i o u s p r e p a r a t i o n s of t h e h u m a n I L - 2 
c o n s t r u c t p G S - M L - 2 t e l assembled i n t o b i o t i n y l a t e d - a d e n o v i r u s - S t r p L -
T f p L - D N A complexes as described in M a t e r i a l s and methods. The e n d o t o x i n 
l e i v l s of t h e p l a s m i d s before p u r i f i c a t i o n are i n d i c a t e d . A f t e r passage t h r o u g h 
p o l y m y x i n r c s i u or c x t r a c t i o n w i t h T r i t o n X - 1 1 4 a l l p r e p a r a t i o n s c o n t a i n e d 
less t h a n 0.1 £U/6 p g D N A . Thesecrcted I L - 2 levels f r o m c u l t u r e 
s u p c r n a t a n t s 2 4 - 4 8 h p o s t - t r a n s f e c t i o n were measured by E L I S A and are 
expressed as u n i t s / 1 0 6 cells/24 h . 
w h i c h w a s s e l d o m m o r e than 5-10 E U / 6 u g D N A 
(comparable to 5-10 n g of L P S , used i n 2-5 m l of cu l ture 
m e d i u m = 1-5 n g / m l ) . H o w e v e r , the toxicity 
demonstrated w i t h the a d d i t i o n of p u r e L P S to cel l 
cultures requires the presence of >50 n g / m l of p u r e L P S 
for toxic i ty measured b y crystal v io le t s ta in ing (F igure 2) 
or >5 u g / m l L P S for toxici ty by M T T reduet ion (Figure 
3). S i m p l e charge considerat ions suggest that the 
negat ive ly charged L P S molecu le c o u l d interact w i t h the 
p o s i t i v e l v charged p o l y l y s i n e of o u r transfect ion 
complexes . W e cons idered the poss ib i l i ty that 
p o l y l y s i n e - L P S complexes , b o u n d to a d e n o v i r u s m i g h t 
be present i n transfect ion complexes p r e p a r e d w i t h L P S -
contaminated D N A preparat ions a n d the l o a d i n g of L P S 
onto p o l y l y s i n e - a d e n o v i r u s complexes m i g h t enhance 
the ce l lu lar interact ions of the L P S molecu le and 
increase the toxic i ty of the L P S molecule . W e tested this 
idea direct ly in the f o l l o w i n g exper iment . 
S tandard b i o t i n y l a t e d - a d e n o v i r u s - S t r p L - T f p L -
D N A complexes were p r e p a r e d . H o w e v e r , the D N A 
used (Tr i ton X-114 extracted to r e m o v e LPS) w a s 
p r e m i x e d w i t h k n o w n quanti t ies of p u r e L P S p r i o r to 
the assembly of the p o l y l y s i n e complexes . The 
complexes were then s u p p l i e d to p r i m a r y f ibroblasts 
and p r i m a r y m e l a n o m a cells a n d the resul t ing toxic i ty 
w a s quant i ta ted b y M T T assay (Figure 5). W e b e g i n to 
observe toxic i ty at concentrat ions of L P S of 5 n g / m l , 
obta ined w i t h a d e n o v i r u s / p o l y l y s i n e / D N A complexes 
c o n t a i n i n g as l ittle as 10 n g of L P S / 6 u g D N A (Figure 5). 
These are concentrat ions c o m p a r a b l e to those that 
p r o d u c e toxic i ty w i t h contaminated D N A a n d are 
toxicities at 10-1000 t imes l o w e r concentrat ions than the 
condi t ions that generate toxic i ty w i t h free L P S a n d 
a d e n o v i r u s mixtures . 
3x10 4 virus/cell 
1000 
L P S (ng/ml) 
F i g u r e 5 T o x i c i t y generated by p r e m i x i n g L P S and D N A before assembly 
i n t o p o l y l y s i n e - a d e n o v i r u s complexes. P r i m a r y h u m a n s k i n f i b r o b l a s t s 
<passage 8 ) were p l a t e d a t 2 0 0 0 cells per w e l l of a 9 6 - w e l l d i s h . Sampties ( i n 
1 0 0 u/ of D M E M , 2% H S ) were ineubated w i t h t h e i n d i c a t e d q u a n t i t y of 
L P S ( S . m i n n e s o t a w i l d t y p e ) in t h e presence o f l O 0 0 0 or 30 0 0 0 
p a r t i c l e s j c e l l of a d e n o v i r u s dllO'14 ( p s o r a l e n i n a c t i v a t e d ) / D N A complexes. 
L P S samples were p r e m i x e d w i t h LPS-free p l a s m i d D N A and assembled i n t o 
a d e n o v i r u s - S t r p L - D N A - T f p L complexes as described in M a t e r i a l s and 
methods. A f t e r 2 h i n e u b a t i o n w i t h t h e l . P S - v i r u s - D N A complexes, a n 
a d d i t i o n a l 150 p l of D M E M / 1 0 7 c FCS was added t o each w e l l ; 48 Ii l a i e r t h e 
m e d i u m was replaced w i t h 1 0 0 p l of D M F M / 1 0 ' 7 , FCS p l u s 15 p l of M T T 
reageut ( P r o m e g a ) and processed for M T T r e d u e t i o n as described in t h e 
legend t o F i g u r e 3. E a c i i p o i n t in t h e g r a p h represents t h e average ofthree 
i n d c p c u d c i i l samples. 
I n c l u d i n g p u r i f i e d LPS in D N A a s s e m b l e d i n t o 
a d e n o v i r u s t r a n s f e c t i o n c o m p l e x e s r e s u l t s in l o s s c f 
g e n e e x p r e s s i o n 
W e have s h o w n that r e m o v i n g the L P S f r o m 
contaminated IL-2 D N A results in an i m p r o v e m e n t of 
gene express ion, most l i k e l y d u e to a n e l i m i n a t i o n of 
toxic i ty (Figure 4). Fur thermore , a d d i t i o n of L P S at 
typica i contaminat ion levels generates toxic i ty w h e n the 
E P S is p r e m i x e d w i t h D N A before assembly in to 
p o l y l y s i n e - a d e n o v i r u s complexes (F igure 5). T o 
establish that a d d i t i o n of p u r e L P S can result i n a 
decl ine in gene express ion, an LPS-free p r e p a r a t i o n of 
the luc i ferase-encoding p l a s m i d p C L u c was p r e m i x e d 
w i t h k n o w n quantit ies of E. c o l i L P S a n d assembled into 
a d e n o v i r u s - p o l v l v s i n e complexes . A l i q u o t s of the 
complexes were then s u p p l i e d to p r i m a r y f ibroblasts 
and 48 h later extracts were p r e p a r e d and luciferase 
gene express ion w a s measured (Figure 6). 
W e f ind that the inc lus ion of as little as 10 n g of 
LPS/6 u g D N A results in a substantial loss in recovered 
luciferase act ivi ty (compare F igure 6, lane 1, no L P S , w i t h 
lane 2,10 n g LPS) . T h i s quant i ty of L P S i n the D N A 
samples results i n a f inal concentrat ion of L P S of 240 
p g / m l . Further decl ine in luciferase gene express ion 
occurs w i t h increasing L P S concentrat ion (F igure 6, lanes 
3 and 4). Substantial toxicity was apparent i n the sample 
2, 3 and 4 cultures and this c o u l d largely aecount for the 
decl ine i n gene act ivity. The toxici ty is apparent i n F igure 
6 at 240 p g / m l LPS , whereas toxicity by M T T assay was 
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F i g u r e 6 D e c l i n e in l u c i f e r a s e a c t i v i t y as a f u n e t i o n of L P S c o n t e n t o f p C L u c 
D N A . P r i m a r y h u m a n s k i n f i b r o b l a s t s (passage 9 ) were p l a t e d a t 20 0 0 0 cells 
per w e l l of a 2 4 - w e l l d i s h in D M E M / 2 r i horse s e r u m . T r a n s f e c t i o n 
complexes c o n t a i n i n g b i o t i n y l a t e d , p s o r a l e n - i n a c t i v a t e d d l l 0 1 4 
a d e n o v i r u s - S t r p L - p C L u c D N A - T f p L and t h e i n d i c a t e d q u a n t i t y of F.. c o l i 
Ol 1 1 : B 4 L P S were prepared as described in M a t e r i a l s and methods. 
Complexes r e p r e s e n t i u g 0.6 p g of D N A and 1 x l O - v i r u s p a r t i c l e s were 
s u p p l i e d t o t h e cells in 500 pd of D M E M / 2 % H S for 2 h a t I T C . A sample of 
1.5 m l of D M E M / 1 0 % FCS was t h e n added t o each sample and 4S h l a i e r t h e 
samples were processed f o r l u c i f e r a s e a c t i v i t y measurement. Each v a l u e 
represents t h e average of t w o i n d e p e n d e n t t r a n s f e c t i o n s . 
not o b s e r v e d b e l o w L P S concentrat ions of 5-50 n g / m l . 
T h i s dif ference i n concentrat ion p r o b a b l y reflects the 
m o d e of assay. W i t h the luciferase assay w e are 
m e a s u r i n g the fate of the cells that ac tual ly endocytose 
the D N A - v i r u s - L P S c o m p l e x whereas w i t h the M T T 
assay w e are m e a s u r i n g the fate of the entire cul ture . 
The toxic i ty does not require the h i g h v i r u s x e l l ratios 
u s e d i n these exper iments . W h e n the d e l i v e r y of a 
luciferase m a r k e r gene is used to f o l l o w the fate of the 
cells that ingest the D N A - L P S c o m p l e x , the toxic i ty at 
1{V v i r u s per cell is c o m p a r a b l e to that at 10 5 v i r u s per 
cel l . Therefore , the toxic i ty d u e to L P S c o n t a m i n a t i o n 
appears u n d e r the same c o n d i t i o n s e m p l o y e d for 
efficient D N A d e l i v e r y . 
D i s c u s s i o n 
P r e v i o u s w o r k has demonstra ted the U t i l i t y of 
a d e n o v i r u s part ic les for e n h a n c i n g the d e l i v e r y of D N A 
to e u k a r y o t i c cells [23-28]. M o s t evicience suggests that 
the p r i m a r y funet ion of the a d e n o v i r u s part ic le i n these 
appl i ca t ions is to increase the c y t o p l a s m i c entry of 
e n d o c y t o s e d mater ia l , a funet ion that w a s i n i t i a l l y 
character ized i n deta i l b y the Pastan a n d C a r r a s c o 
g r o u p s [29, 30]. T h i s enhanced in t race l lu lar d e l i v e r y of 
mater ia l a p p l i e s to toxins as w e l l as to the D N A 
molecules that w e seek to de l iver . E n d o t o x i n (LPS) is a 
c o m m o n c o n t a m i n a n t of E. co//'-grown p l a s m i d D N A 
preparat ions . These L P S c o n t a m i n a t i o n s are s i m p l e to 
o v e r l o o k because the m o l e c u l e is not v i s u a l i z e d either 
b y e t h i d i u m b r o m i d e s t a i n i n g or b y absorbance at 260 
n m , the t w o m e t h o d s c o m m o n l y u s e d to a n a l y z e a n d 
quant i fy D N A preparat ions . W e have demonst ra ted 
here that the levels of e n d o t o x i n c o n t a m i n a t i n g D N A 
preparat ions can be toxic to p r i m a r y cells i n the presence 
of entry-act ive a d e n o v i r u s particles . W e have 
demonst ra ted that D N A p u r i f i e d w i t h techniques for 
r e m o v i n g c o n t a m i n a t i n g L P S molecules enhances gene 
express ion i n p r i m a r y cells a n d e l iminates the toxic i ty . 
It is not yet clear if the tox ic i ty is d u e to p h y s i c a l 
damage to the cell b y the L P S , if the c y t o p l a s m i c 
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d e l i v e r y of L P S is a s igna l or if the c o m b i n e d interact ion 
of a d e n o v i r u s particles a n d L P S molecules activates a 
toxic s i g n a l l i n g p a t h w a y . E x p e r i m e n t s to c lar i fy the 
m e c h a n i s m generat ing this toxic i ty are i n progress. 
The use of a d e n o v i r u s particles to enhance reeeptor-
mediated gene de l ivery is a p o w e r f u l technique, 
generating h i g h levels of transient gene expression i n a 
variety of cell types. H o w e v e r , the use of this System i n 
v i v o for long- term expression has beert hampered by the 
r a p i d decay i n gene expression [31]. O u r Observation that 
the L P S c o m m o n l y contaminat ing D N A preparat ions is 
responsible for a toxicity, and the demonstrat ion here of a 
s imple r e m e d y for this p r o b l e m , s h o u l d increase the 
U t i l i t y of this transfection method for p r i m a r y cells. 
M a t e r i a l s a n d m e t h o d s 
D N A p r e p a r a t i o n 
A l l D N A p l a s m i d s carr ied either the ß-lactamase 
a m p i c i l l i n resistance gene or the tetraeycline resistance 
gene a n d w e r e propagated in the bacterial strains HB101 
or D H 5 a i n the presence of 100 u g / m l a m p i c i l l i n or 5 
U g / m l tetraeycline i n either L B or Terr i f ic m e d i u m [32]. 
Saturated o v e r n i g h t cul tures of the p l a s m i d - t r a n s f o r m e d 
bacter ial strains were p r e p a r e d , collected b y 
centr i fugat ion a n d processed for p l a s m i d D N A 
p u r i f i c a t i o n i n the f o l l o w i n g manner . 
CsCl. T h i s p r o c e d u r e is descr ibed i n detai l 133]. Br ie f ly , 
the bacterial pellet f r o m a 1-liter cu l ture w a s s u s p e n d e d 
i n 10 m l of 20% (w/v) sucrose, 10 m M E D T A , 50 m M Tr is 
p H 7.5 (Solution 1) ineubated o n ice for 10 m i n , 2.2 m l 
l y s o z y m e (10 m g / m l i n So lut ion 1) was a d d e d for an 
a d d i t i o n a l 10 m i n o n ice, 5 m l 0.2 m E D T A p H 7 was 
a d d e d a n d the s a m p l e w a s ineubated for 10 m i n on ice 
a n d f ina l ly , 10 m l 2% (v/v) T r i t o n X-114, 60 m M E D T A 
and 40 m M Tr i s p H 7.5 were a d d e d f o l l o w e d b y 
ineubat ion for 15 m i n o n ice. T h i s lysate w a s then 
centr i fuged for 30 m i n (Sorval l SS34 ,17K) and 28.5 g 
C s C l and 400 u l e t h i d i u m b r o m i d e (10 m g / m l ) were 
a d d e d to the supernatant (26 m l in i t ia l v o l u m e ) . The 
mater ia l w a s centr i fuged for >18 h i n a B e c k m a n V T i 5 0 
rotor at 200 000 x g at 20°C. T h e l o w e r of the t w o 
e t h i d i u m - r i c h b a n d s w a s collected a n d centr i fuged 
again , i n a B e c k m a n V T i 6 5 rotor for >4 h at 350 000 x g at 
20°C. T h e e t h i d i u m - r i c h b a n d w a s a g a i n harvested, 
extracted w i t h C s C l - s a t u r a t e d i s o p r o p a n o l u n t i l the p i n k 
e t h i d i u m color w a s gone, d i a l y z e d extensively against 
T E (10 m M Tr i s , 0.1 m M E D T A p H 7.4), m i x e d w i t h 1/10 
v o l . 3 m s o d i u m acetate p H 5.0 and preeipi tated w i t h 
3 v o l . of e thanol at - 2 0 ° C . The collected D N A preeipitate 
w a s further processed w i t h R N a s e A , proteinase K , 
p h e n o l / c h l o r o f o r m a n d C h l o r o f o r m , repreeipitated a n d 
the f inal D N A pellet w a s s u s p e n d e d i n T E a n d 
quant i f i ed b y opt ica l absorbance, a s s u m i n g that 0.05 
m g / m l D N A has an absorbance at 260 n m of 1. 
Q i a g e n a n d N u c l e o b o n d . Q i a g e n (Diagen G m b H , H i l d e n , 
G e r m a n y ) a n d N u c l e o b o n d ( M a c h e r e y - N a g e l , Düren, 
G e r m a n y ) p l a s m i d D N A resins were used f o l l o w i n g the 
direct ions s u p p l i e d b y the manufacturers , w i t h the 
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exceprion that N u c l e o b o n d c o l u m n s were r insed four 
times w i t h h i g h stringency w a s h buffer (rather than 
twice) f o l l o w i n g b i n d i n g of the D N A to the resin. 
T r i t o n X - 1 1 4 e x t r a c t i o n . T r i t o n X-114 (Sigma) w a s passed 
t h r o u g h three 0°C/30°C temperature cycles (as 
descr ibed b y B o r d i e r [14]) to isolate a h o m o g e n e o u s 
prepara t ion of the detergent. Extract ion of L P S f r o m 
D N A samples w a s p e r f o r m e d as f o l l o w s , a m o d i f i c a t i o n 
of p r e v i o u s l y p u b l i s h e d m e t h o d s [15,16]. D N A samples 
at 0.5-1.5 m g / m l in T E were adjusted to 0.3 M s o d i u m 
acetate p H 7.5. T r i t o n X-114 (3 u l per 100 u l D N A 
Solution) was a d d e d and the samples were vortexed 
t h o r o u g h l y a n d ineubated o n ice for 10 m i n . The 
samples were then transferred to 30°C for 5 m i n to a l l o w 
the t w o phases to separate, centr i fuged in a p r e w a r m e d 
E p p e n d o r f centr i fuge (ca. 30°C) for 2 m i n at 2000 a n d 
the aqueous phase w a s transferred to a fresh E p p e n d o r f 
tube. T h i s extract ion was repeated t w o a d d i t i o n a l t imes 
and the D N A i n the f ina l aqueous phase was 
preeipitated w i t h 0.6 v o l . of i s o p r o p a n o l at r o o m 
temperature. The preeipitate w a s collected b v 
centr i fugat ion , w a s h e d twice w i t h 80% ethanol ( -20°C) , 
a i r - d r i e d , resuspencied in T E and quant i f i ed . 
P o l y m y x i n B c h r o m a t o g r a p h y 
A v o l u m e of p o l y m y x i n B resin s lurry ( A f f i - P r e p p o l y -
m y x i n , B ioRad) equal to the D N A sample v o l u m e w a s 
brief ly exposed to 3 v o l . 0.1 N N a O H , f o l l o w e d b y three 
washes of f ive resin v o l u m e s w i t h T E (10 m M Tris , 0.1 m M 
E D T A p H 7.4). The pelleted resin was resuspended w i t h 
the D N A samples (in T E at 0.8-1.2 m g / m l ) and the 
mix ture was agitated b y rotation overnight at 4°C. The 
sample was then transferred to a disposable c o l u m n 
(BioRad, Poly-Prep) that had been pretreated w i t h 0.1 N 
N a O H and washed w i t h T E . The eiuate was collected, the 
resin was washed w i t h an addi t iona l bed v o l u m e of T E 
and the eiuate p l u s w a s h were p o o l e d . The D N A in this 
pooled sample w a s preeipitated w i t h 1/10 v o l . 3 \i 
s o d i u m acetate p H 5 and 2 v o l . of ethanol . The preeipitate 
was collected, w a s h e d w i t h 80% ethanol , d r i e d , d i sso lved 
i n T E and quant i f ied as described above. 
LPS p r e p a r a t i o n s 
A s speeified in the figure legends, the pure L P S 
preparations used in these studies were either a smooth 
L P S f rom S. m i n n e s o t a , extracted b v the phenol/water 
method and further pur i f i ed bv gel f i l tration, a s imi lar 
preparat ion of L P S f r o m £. c o l i 011LB4 or L P S f rom the 
S. m i n n e s o t a r o u g h mutant Re 595 (all f r o m Sigma). A l l 
three L P S types y i e l d e d s imi lar results. L P S preparations 
were suspended i n LPS-free water b y sonication for 5 m i n 
in a Transsonix 5 7 0 / H (360 W ) sonicat ing bath . Serial 
d i l u t i o n s were prepared in LPS-free water w i t h 30 s of 
v o r t e x i n g between d i l u t i o n s . The f inal d i l u t i o n s were 
sonicated for 5 m i n before use. 
Virus p r o c u r e m e n t . b i o t i n y l a t i o n a n d p s o r a l e n 
i n a c t i v a t i o n 
The E4-defect ive a d e n o v i r u s 5, d l l 0 1 4 [34] w a s g r o w n 
o n the c o m p l e m e n t i n g cel l l ine W 1 6 2 [35]. Pellets of 
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infected cells were s u s p e n d e d in 20 m M h y d r o x y -
e t h v l p i p e r a z i n e sulfonate ( H E P E S ) p H 7.4, 1 m\i 
p h e n y l m e t h y l s u l f o n y l f l u o r i d e ( P M S F ) at 2 m l per 3 x 
10' cells a n d subjected to three f reeze/thaw cycles 
( l i q u i d n i t rogen , 37°C) . T h e Suspension w a s then m i x e d 
w i t h an equal v o l u m e of F r e o n a n d vor texed for 3 x 30-s 
bursts a n d centr i fuged 10 m i n at 1700 x g (Heraeus 
Sepatech, 2705 rotor) . T h e aqueous phase (upper) was 
saved and the F r e o n phase w a s v o r t e x e d w i t h 1/5 v o l . 
20 mvi H e p e s p H 7.4 a n d centr i fuged as before. The 
aqueous phases were p o o l e d , transferred to a B e c k m a n 
V T i 5 0 centr i fuge tube (15 ml/tube) a n d u n d e r l a v e d w i t h 
15 m l of 1.2 g / c m 3 C s C l , 20 mvi H e p e s p H 7.4 a n d then 
w i t h 7 m l of 1.45 g / c m 3 C s C l , 20 m M H e p e s p H 7.4. The 
samples w e r e centr i fuged at 200 000 x g in a B e c k m a n 
VT150 rotor for 40 m i n at 20°C. The l o w e r opalescent 
b a n d of m a t u r e v i r u s particles at 1.34-1.35 g / c m 3 (as 
measured b y refract ive index) a n d the u p p e r b a n d 
( immature particles at 1.31-1.32 g / c m 1 ) w e r e collected 
separately and centr i fuged to e q u i l i b r i u m (>4 h) at 
350 000 x g in a V T i 6 5 rotor. The opalescent v i r u s bands 
(either 1.31 g / c m 3 for i m m a t u r e or 1.34 g / c m 3 for 
mature) w e r e harvested a n d either processed d i r e c t l y 
for b i o t i n y l a t i o n a n d psoralen inac t iva t ion or d i l u t e d 
w i t h an equal v o l u m e of 86% g l y c e r o l (Fluka) a n d stored 
a t - 8 0 ° C . 
V i r u s b i o t i n y l a t i o n w i t h N - h y d r o x y s u c c i n i m i d e -
b i o t i n (Pierce), i n a c t i v a t i o n w i t h 8 - m e t h o x y p s o r a l e n / 
360 n m U V l ight and p u r i f i c a t i o n by gel f i l t ra t ion u s i n g 
a P h a r m a c i a P D 1 0 c o l u m n e q u i l i b r a t e d w i t h H E P E S -
buffered sal ine ( H B S , 150 m M N a C l , 20 m M H E P E S 
p H 7 . 4 ) / 4 0 % g lycero l were p e r f o r m e d as descr ibed 
p r e v i o u s l y [21, 22]. V i r u s samples were q u a n t i f i e d by 
prote in concentrat ion (B ioRad B r a d f o r d assay w i t h 
b o v i n e s e r u m a l b u m i n , B S A , as a Standard) u s i n g the 
re la t ionship of 1 m g / m l prote in = 3.4 x 10 1 2 a d e n o v i r u s 
par t i c l es/ml [36]. 
C e l l c u l t u r e 
P r i m a r y h u m a n m e l a n o m a cul tures w e r e isolated a n d 
g r o w n i n R P M I - 1 6 4 0 m e d i u m ( G I B C O / B R L ) 
s u p p l e m e n t e d w i t h 100 I U / m l p e n i c i l l i n , 100 u g / m l 
s t reptomyein , 2 m M I - g l u t a m i n e , 1% s o d i u m p y r u v a t e 
a n d 10% heat- inact ivated (30 m i n , 56°C) fetal calf s e r u m 
( R P M I / 1 0 % F C S ) . P r i m a r y h u m a n s k i n f ibroblasts were 
isolated f r o m s k i n biopsies and p r o p a g a t e d in 
Dulbecco ' s m o d i f i e d Eagle 's m e d i u m ( D M E M ) p l u s 2 
m M g l u t a m i n e , 50 u g / m l g e n t a m i c i n a n d 10% heat-
inact ivated fetal calf s e r u m ( D M E M / 1 0 % FCS) . T h e 
p r i m a r y f ibroblast cultures were u s e d at passage 5—10; 
p r i m a r y m e l a n o m a cul tures were used at passage 16-25 
for these exper iments . 
P r e p a r a t i o n of a d e n o v i r u s - D N A c o m p l e x e s 
StrpL and T f p L were prepared as p r e v i o u s l y described 
[23,37]. Samples of b iot inylated, psoralen- inact ivated 
adenovirus d l l 0 1 4 (8 ul, 1 x 10 1 2 part ic les/ml) w e r e 
d i lu ted into 150 ul H B S a n d m i x e d w i t h 1 ug S t r p L in 150 
ul H B S for 30 m i n at r o o m temperature. A l i q u o t s of 6 ug 
plasmid D N A were d i l u t e d i n 100 ul conta in ing the 
indicated quantities of L P S (see f igure legends). The D N A 
Gene T h e r a p y 
LPS t o x i c i t y i n the presence of adenovirus 
(LPS) Solutions were then m i x e d w i t h the adenovirus— 
St rpL Solut ion for 30 m i n at r o o m temperature. F ina l ly , a 
100-ui a l iquot of H B S conta in ing 5 (ig T f p L was a d d e d to 
each sample , f o l l o w e d b y incubat ion for 30 m i n at r o o m 
temperature. A l i q u o t s of these transfection complexes 
were then s u p p l i e d to cells as described i n the f igure 
legends (generally 5-50 u l per 20 000-50 000 cells). 
C e l l v i a b i l i t y a s s a y s 
C r y s t a l violet s ta in ing w a s p e r f o r m e d 48-72 h after 
exposure of cel l samples to test agents. The cul ture 
m e d i u m w a s r e m o v e d , the cell layer w a s w a s h e d once 
w i t h H B S , f i x e d for 5 m i n w i t h 4% f o r m a l d e h y d e / 1 5 0 
m v i N a C l a n d then stained for 10 m i n w i t h 0.1% crystal 
v io le t i n 2% ethanol . The s ta in ing Solut ion w a s then 
r e m o v e d a n d the w e l l w a s h e d once w i t h phosphate-
b u f f e r e d saline (PBS) and once w i t h d is t i l l ed water . A n 
al ternat ive d e t e r m i n a t i o n of ce l l v i a b i l i t y w a s p e r f o m e d 
u s i n g the M T T reduet ion assay [38] as m o d i f i e d bv 
P r o m e g a . 
E n d o t o x i n (LPS) a s s a y s 
L P S w a s measured w i t h the B i o W h i t t a k e r Q C L - 1 0 0 0 
c h r o m o g e n i c L i m u l u s assay, based o n the L i m u l u s 
amoebocyte c lot t ing react ion ( rev iewed i n [39]). A l l 
S o l u t i o n s used for D N A a n d v i r u s preparat ions as w e l l 
as T f p L , S t r p L a n d a d e n o v i r u s preparat ions were 
demonstra ted to be L P S free (<0.1 e n d o t o x i n units/50 u l 
Solution) before use. 
M i s c e l l a n e o u s 
Luci ferase gene express ion w a s measured as descr ibed 
p r e v i o u s l y 133]. H u m a n IL-2 in cell cu l ture supernatants 
w a s d e t e r m i n e d be tween 24 and 48 h after transfection 
by E L I S A (T C e l l Diagnost ics Inc., C a m b r i d g e , M A , 
U S A ) . Supernatants w e r e col lected, centr i fuged at about 
3000 x g in an E p p e n d o r f M i c r o f u g e to r e m o v e debris 
and stored at - 2 0 ° C u n t i l assayed. V a l u e s reported are in 
B R M P (Biological Response Moc i i f i e r Program) Units per 
10 6 cells per 24 h . 
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